Paul Balderes

Paul Balderes

UNVERIFIED PROFILE

Are you Paul Balderes?   Register this Author

Register author
Paul Balderes

Paul Balderes

Publications by authors named "Paul Balderes"

Are you Paul Balderes?   Register this Author

21Publications

921Reads

50Profile Views

Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes.

Biotechnol Bioeng 2013 Nov 29;110(11):2928-37. Epub 2013 Jun 29.

Bioprocess Sciences, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, 450 East 29th Street, New York, New York, 10016.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bit.24969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812681PMC
November 2013

Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.

Hum Antibodies 2007 ;16(3-4):127-36

ImClone Systems Incorporated, 180 Varick Street, New York, NY 10014, USA.

View Article

Download full-text PDF

Source
April 2008

Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.

J Immunol Methods 2007 Jan 26;318(1-2):65-74. Epub 2006 Oct 26.

Department of Antibody Technology, Department of Cell Engineering and Expression, ImClone Systems Incorporation, 180 Varick Street, New York, NY 10014, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2006.09.020DOI Listing
January 2007

Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2.

Biochem Biophys Res Commun 2006 Jun 2;345(1):438-45. Epub 2006 May 2.

Departments of Antibody Technology, Protein Science, and Cell Engineering and Expression, ImClone Systems Incorporated, New York, NY 10014, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2006.04.119DOI Listing
June 2006

Di-diabody: a novel tetravalent bispecific antibody molecule by design.

J Immunol Methods 2003 Aug;279(1-2):219-32

Department of Antibody Technology, ImClone Systems Incorporated, New York, NY 10014, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-1759(03)00251-5DOI Listing
August 2003